Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Methylation-based signature to distinguish indolent and aggressive prostate cancer.

Biology open·2025
Same author

Integration of Short- and Long-Read RNA Sequencing Enables the Discovery of Circular RNAs.

Cancer research·2025
Same author

Leveraging sequences missing from the human genome to diagnose cancer.

Communications medicine·2025
Same author

Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Overexpression of human DNA polymerase theta is a biomarker of aggressive and DNA repair-deficient papillary thyroid cancers.

Surgery·2024
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
Same journal

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same journal

Critical evaluation of the key mediators causing life-threatening symptoms during human anaphylaxis.

Drug discovery today·2026
Same journal

A20 as a novel immunoregulatory target for neuroinflammation.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.4K

Clonotyping for precision oncology.

Ha X Dang1, Christopher A Maher2

  • 1McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO 63110, USA; Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO 63110, USA.

Drug Discovery Today
|October 24, 2015
PubMed
Summary
This summary is machine-generated.

Understanding cancer cell subpopulations and tumor evolution aids personalized medicine. Monitoring clonal dynamics is key for targeted therapies and overcoming resistance, especially in prostate cancer (PCa).

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K

Related Experiment Videos

Last Updated: Mar 31, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.4K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K

Area of Science:

  • Oncology
  • Genomics
  • Bioinformatics

Background:

  • Identifying cancer cell subpopulations and reconstructing tumor clonal evolution enhances understanding of molecular events.
  • Monitoring clonal dynamics in personalized medicine is crucial for targeted therapies and understanding resistance mechanisms.

Purpose of the Study:

  • To review advances in biotechnology and bioinformatics for dissecting clonal evolution.
  • To highlight applications in lymphomas, leukemias, and prostate cancer (PCa).

Main Methods:

  • Review of current biotechnological tools for analyzing cancer genomes.
  • Application of bioinformatics approaches to reconstruct tumor phylogenies.
  • Case studies from hematologic malignancies and solid tumors, including PCa.

Main Results:

  • Technological and computational advances enable precise dissection of tumor clonal architecture.
  • Clonal evolution insights inform therapeutic strategies and resistance prediction.
  • Demonstrated utility across diverse cancer types, from blood cancers to PCa.

Conclusions:

  • Dissecting clonal evolution is pivotal for advancing precision oncology.
  • Biotechnology and bioinformatics are key drivers in personalized cancer care.
  • Further research into clonal dynamics will refine targeted treatment paradigms for cancers like PCa.